Credit Trends: U.S. Composite Credit Spreads Daily (June 7, 2011) Jun 11

  • ID: 1815183
  • June 2011
  • Region: United States
  • Standard & Poors
1 of 2

Standard & Poor's investment-grade composite spread widened one basis point yesterday to 170 basis points (bps), and the speculative-grade composite spread widened by 2 bps to 523 bps. By rating, the 'AA' spread widened by one basis point to 121 bps, 'A' remained flat at 150 bps, and 'BBB' expanded by 2 bps to 200 bps. The 'BB' spread widened by one basis point to 382 bps, and 'B' and 'CCC' expanded by 4 bps each, to 556 bps and 785 bps, respectively. By industry, financial institutions, industrials, and utilities each widened by one basis point, to 258 bps, 258 bps, and 175 bps, respectively. Banks expanded by 2 bps to 220 bps, and telecommunications widened by 5 bps to...

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Commentary
Criteria articles describe the thought process and methodology Standard & Poor's analysts use in determining ratings. These commentary pieces discuss both the quantitative (economic and financial) and qualitative (business analysis and caliber of management) aspects of the analysis, as well as legal issues.

Note: Product cover images may vary from those shown
2 of 2
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.